e-cel uvec
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2019 (NCT04057833)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04190862 | Phase 1 | Dec 5, 2019 | Angiocrine Bioscience, Cornell University |
| NCT04057833 | Phase 1 | Sep 1, 2019 | Orthopedic Research and Education Foundation, Rockefeller University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Angiocrine Bioscience | For profit | 1 | 0 | 1 | 2019 |
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Orthopedic Research and Education Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Rockefeller University | Academic/Hospital | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1